Cue Biopharma, Inc. Shares Outstanding
Cue Biopharma, Inc. (CUE) had Shares Outstanding of 5.23 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-14
- 2026-06-30: Shares outstanding (split-adjusted) 5.23M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 3.26M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 3.22M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 77.78M shares; Shares authorized (split-adjusted) 300.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 5.23M shares 10-Q · filed 2026-08-14 | 300.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 3.26M shares 10-Q · filed 2026-05-14 | 300.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 3.22M shares 10-Q · filed 2026-08-14 | 300.00M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 77.78M shares 10-Q · filed 2025-11-12 | 300.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 76.45M shares 10-Q · filed 2025-08-12 | 300.00M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 61.82M shares 10-Q · filed 2025-05-12 | 200.00M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 61.82M shares 10-K · filed 2026-03-16 | 200.00M shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 60.21M shares 10-Q · filed 2024-11-14 | 100.00M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 48.64M shares 10-Q · filed 2024-08-14 | 100.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 48.64M shares 10-Q · filed 2024-05-09 | 100.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 47.22M shares 10-K · filed 2025-03-31 | 100.00M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 45.12M shares 10-Q · filed 2023-11-03 | 100.00M shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 43.74M shares 10-Q · filed 2023-08-08 | 100.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 43.18M shares 10-Q · filed 2023-05-09 | 100.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 47.22M shares 10-K · filed 2024-03-28 | 100.00M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 35.39M shares 10-Q · filed 2022-11-14 | 100.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 35.38M shares 10-Q · filed 2022-08-04 | 100.00M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 34.17M shares 10-Q · filed 2022-05-10 | 100.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 32.20M shares 10-K · filed 2023-03-21 | 100.00M shares 10-K · filed 2023-03-21 |
| 2021-09-30 | 31.36M shares 10-Q · filed 2021-11-09 | 100.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 31.47M shares 10-Q · filed 2021-08-09 | 100.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 30.50M shares 10-Q · filed 2021-05-10 | 100.00M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 30.35M shares 10-K · filed 2022-03-16 | 100.00M shares 10-K · filed 2022-03-16 |
| 2020-09-30 | 30.25M shares 10-Q · filed 2020-11-09 | 100.00M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 29.30M shares 10-Q · filed 2020-08-07 | 50.00M shares 10-Q · filed 2020-08-07 |
| 2020-03-31 | 26.58M shares 10-Q · filed 2020-05-07 | 50.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 26.56M shares 10-K · filed 2021-03-09 | 100.00M shares 10-K · filed 2021-03-09 |
| 2019-09-30 | 22.97M shares 10-Q · filed 2019-11-07 | 50.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 21.31M shares 10-Q · filed 2019-08-08 | 50.00M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 20.78M shares 10-Q · filed 2019-05-08 | 50.00M shares 10-Q · filed 2019-05-08 |
| 2018-12-31 | 20.70M shares 10-K · filed 2020-03-12 | 50.00M shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 20.13M shares 10-Q · filed 2018-11-13 | 50.00M shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 20.13M shares 10-Q · filed 2018-08-13 | 50.00M shares 10-Q · filed 2018-08-13 |
| 2018-03-31 | 20.13M shares 10-Q · filed 2018-05-14 | 50.00M shares 10-Q · filed 2018-05-14 |
| 2017-12-31 | 19.46M shares 10-K · filed 2019-03-14 | 50.00M shares 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |